Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd. has shown strong stock performance, with notable gains over various time frames. The company maintains a solid financial position, highlighted by a market capitalization of CNY 10,432 million, a low debt-to-equity ratio, and a dividend yield of 2.1%.

Zhejiang Hisun Pharmaceutical Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. Despite recent gains over the past week and month, the company has faced challenges over the past year. Financial metrics indicate a stable position with a low debt-to-equity ratio.

Zhejiang Hisun Pharmaceutical Co., Ltd. saw a significant stock increase on July 13, 2026, reaching an intraday high amid a declining broader market. The company has shown positive weekly and monthly trends, with solid financial metrics, including a return on equity of 5.96% and a dividend yield of 2.1%.

Zhejiang Hisun Pharmaceutical Co., Ltd. has experienced notable stock activity, achieving an intraday high and a significant monthly increase. Despite facing annual challenges, the year-to-date performance is positive. The company's financial metrics, including a return on equity and dividend yield, suggest a solid valuation in the pharmaceuticals sector.

Zhejiang Hisun Pharmaceutical Co., Ltd. has experienced notable stock performance, rising significantly today and over the past week. Despite recent gains, the company faces long-term challenges with declines over three and five years. It maintains a solid market capitalization and offers a dividend yield, highlighting its shareholder value commitment.

Zhejiang Hisun Pharmaceutical Co., Ltd. faced a challenging trading day on June 16, 2026, with a notable stock decline. Despite recent weekly gains, the company's performance over the past month and longer periods has been unfavorable. It currently holds a market capitalization of CNY 10,432 million.

Zhejiang Hisun Pharmaceutical Co., Ltd. experienced notable stock activity, reaching an intraday high and outperforming the China Shanghai Composite index for the day. The company has shown resilience year-to-date and over the past year, with solid returns and a market capitalization of CNY 11,262 million.

Zhejiang Hisun Pharmaceutical Co., Ltd. has seen a significant rise in stock performance, reaching an intraday high and reflecting positive market sentiment. Over the past year, the company has outperformed the broader market index, despite recent short-term challenges. It maintains a strong financial position within the pharmaceuticals sector.

Zhejiang Hisun Pharmaceutical Co., Ltd. saw a notable decline in its stock price, contrasting with the broader market's performance. Over the past week and month, the stock has decreased significantly, while year-to-date figures show a slight drop. The company maintains a market capitalization of CNY 11,262 million and a price-to-earnings ratio of 25.00.

Zhejiang Hisun Pharmaceutical Co., Ltd. has shown strong performance recently, with a year-to-date increase of 4.85% and a one-year return of 21.71%. The company, with a market capitalization of CNY 11,262 million, maintains a price-to-earnings ratio of 25.00 and a dividend yield of 2.25%.